INACTIVATION OF SELECTED NIAID PROGRAM ANNOUNCEMENTS

Release Date:  May 1, 1998

P.T.

National Institute of Allergy and Infectious Diseases

The National Institute of Allergy and Infectious Diseases (NIAID) regularly
reviews its portfolio of active program announcements.  When the objectives of
PAs have been attained, NIAID announces inactivation of those PAs.

NIAID supports highly scientifically meritorious applications in all areas of
research within its mission.  Except when otherwise noted below, PA inactivation
simply means that special consideration for funding beyond normal paylines will
NO LONGER be given to applications on the research topics identified in the
inactivated PAs.  However, such applications will be accepted, reviewed, and
considered for funding according the usual procedures.

At any time, potential applicants can obtain a current listing of active NIAID
PAs on the NIAID WWW site at URL:  http://www.niaid.nih.gov/ncn/budget/pas.htm

INACTIVATIONS.  The following program announcements (PAs) are being inactivated;
NIAID will no longer give special consideration for funding to applications in
response to these PAs.  This notice is effective immediately and applies to the
application receipt deadlines of July 1, 1998 and after.

PA-93-041   Minority Investigators in Asthma and Allergy, Jan 22, 1993
PA-94-019   Infectious Causes of Diarrhea/Wasting Syndrome in People with AIDS,
		Dec 17, 1993
PA-94-092   New Insights into Chronic Fatigue Syndrome, Aug 4, 1994
PA-94-095   Drug Discovery for Opportunistic Infections Associated with AIDS,
		Sep 16, 1994
PAR-95-047  National Cooperative Drug Discovery Groups, HIV Treatment,
		April 14, 1995
PAR-96-060  Acute Infection and Early Disease Research Network, Jun 28, 1996

(NOTE:  THE FINAL RECEIPT DATE OF SEPTEMBER 1, 1998 IS CANCELED BECAUSE ADEQUATE
NETWORK MEMBERSHIP HAS BEEN ACHIEVED.)

PA-96-061   Modern Vaccines for Mycoses and Measles, June 21, 1996
		(NOTE: REPLACED BY PA-98-039, Modern Vaccines for Mycoses, March 3, 1998)
PA-96-072,  Mechanisms of AIDS Pathogenesis, September 6, 1996
		(NOTE: WILL BE REPLACED BY A RELATED PA, Collaborative HIV/AIDS
		Research Teams)

INQUIRIES

For questions or further information, contact:

Office of the Director
Division of Extramural Activities
National Institute of Allergy and Infectious Diseases
Solar Building, Room 3C20
Bethesda, MD  20892-7610
Telephone:  (301) 496-7291
FAX:  (301) 402-0369
Email:  [email protected]

Return to Volume Index

Return to NIH Guide Main Index

	Office of Extramural Research (OER)			National Institutes of Health (NIH) 9000 Rockville Pike Bethesda, Maryland 20892			Department of Health and Human Services (HHS)